Concert Pharmaceuticals Inc (CNCE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CNCE Annual Balance Sheets →
The table below presents a historical view of Concert Pharmaceuticals Inc's balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2022)
(Jun 30 2022) (Mar 31 2022) (Dec 31 2021) (Sep 30 2021)
Assets
Cash & cash equivalent95.19
Marketable Securities, Current SH0.68
Cash & Short-term Investments95.00
Accounts receivable1.44
Interest Receivable, Current0.21
Deferred Costs, Current AS0.02
Other Current Assets53.67
Prepaid Expense And Other Assets Current6.00
Total Current Assets157.20
Equipment/Property/Plant Net4.57
Other Assets, Noncurrent9.00
Operating Lease Right Of Use Asset8.21
Restricted Cash Noncurrent1.16
Total Assets171.13
Liabilities
Accounts Payable, Current AC2.75
Accrued Liabilities And Other Liabilities13.31
Other Liabilities, Current1.35
Total Current Liabilities17.40
Total Long-term Debt0.00
Other liabilities, Noncurrent20.46
Operating Lease Liability Current1.35
Contract With Customer Liability Noncurrent7.60
Total Liabilities37.86
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock573.41
Retained Earnings / Accumulated Deficit-440.05
Other Equity-0.13
Common Stockholder's Equity133.27
Total Stockholder's Equity133.27
Liabilities & Stockholder's Equity171.13
4 historic quarters locked

Sign in to unlock the full Concert Pharmaceuticals Inc balance sheet history.

About Concert Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001367920-22-000075

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.